{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:06:56Z","timestamp":1788923216556,"version":"build-2803163510"},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":3970,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.jpainsymman.2008.02.016","type":"journal-article","created":{"date-parts":[[2008,8,20]],"date-time":"2008-08-20T14:15:11Z","timestamp":1219241711000},"page":"363-372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Long-Term Intrathecal Ziconotide for Chronic Pain: An Open-Label Study"],"prefix":"10.1016","volume":"37","author":[{"given":"Lynn R.","family":"Webster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Charapata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jpainsymman.2008.02.016_bib1","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1021\/bi00382a004","article-title":"Neuronal calcium channel antagonists. Discrimination between calcium channel subtypes using omega-conotoxin from Conus magus venom","volume":"26","author":"Olivera","year":"1987","journal-title":"Biochemistry"},{"key":"10.1016\/j.jpainsymman.2008.02.016_bib2","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1146\/annurev.pa.35.040195.003423","article-title":"Antagonists of neuronal calcium channels: structure, function, and therapeutic implications","volume":"35","author":"Miljanich","year":"1995","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"3","key":"10.1016\/j.jpainsymman.2008.02.016_bib3","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0022-3565(25)21283-6","article-title":"Selective N-type neuronal voltage-sensitive calcium channel blocker, SNX-111, produces spinal antinociception in rat models of acute, persistent and neuropathic pain","volume":"279","author":"Bowersox","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.jpainsymman.2008.02.016_bib4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0304-3959(94)00094-U","article-title":"Effect of continuous intrathecal infusion of omega-conopeptides, N-type calcium-channel blockers, on behavior and antinociception in the formalin and hot-plate tests in rats","volume":"60","author":"Malmberg","year":"1995","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.jpainsymman.2008.02.016_bib5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/jama.291.1.63","article-title":"Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial","volume":"291","author":"Staats","year":"2004","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jpainsymman.2008.02.016_bib6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1525-1403.2006.00055.x","article-title":"Intrathecal ziconotide in the treatment of chronic nonmalignant pain: a randomized, double-blind, placebo-controlled clinical trial","volume":"9","author":"Wallace","year":"2006","journal-title":"Neuromodulation"},{"issue":"5","key":"10.1016\/j.jpainsymman.2008.02.016_bib7","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jpainsymman.2005.10.003","article-title":"A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain","volume":"31","author":"Rauck","year":"2006","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"10.1016\/j.jpainsymman.2008.02.016_bib8","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/S0885-3924(00)00202-5","article-title":"Clinical guidelines for intraspinal infusion: report of an expert panel. PolyAnalgesic Consensus Conference 2000","volume":"20","author":"Bennett","year":"2000","journal-title":"J Pain Symptom Manage"},{"issue":"6","key":"10.1016\/j.jpainsymman.2008.02.016_bib9","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jpainsymman.2004.03.001","article-title":"Polyanalgesic Consensus Conference 2003: an update on the management of pain by intraspinal drug delivery\u2014report of an expert panel","volume":"27","author":"Hassenbusch","year":"2004","journal-title":"J Pain Symptom Manage"},{"issue":"4","key":"10.1016\/j.jpainsymman.2008.02.016_bib10","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1525-1403.2007.00128.x","article-title":"Polyanalgesic Consensus Conference 2007: recommendations for the management of pain by intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel","volume":"10","author":"Deer","year":"2007","journal-title":"Neuromodulation"},{"issue":"1","key":"10.1016\/j.jpainsymman.2008.02.016_bib11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1525-1403.2007.00141.x","article-title":"Continuous intrathecal infusion of ziconotide for treatment of chronic malignant and nonmalignant pain over 12 months: a prospective, open-label study","volume":"11","author":"Ellis","year":"2008","journal-title":"Neuromodulation"},{"issue":"2","key":"10.1016\/j.jpainsymman.2008.02.016_bib12","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1213\/ane.0b013e3181606fad","article-title":"Intrathecal ziconotide for severe chronic pain: safety and tolerability results of an open-label, long-term trial","volume":"106","author":"Wallace","year":"2008","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jpainsymman.2008.02.016_bib13","series-title":"PRIALT [package insert]","year":"2007"},{"issue":"2","key":"10.1016\/j.jpainsymman.2008.02.016_bib14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"J Pain"},{"issue":"23","key":"10.1016\/j.jpainsymman.2008.02.016_bib15","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.2174\/0929867043363884","article-title":"Ziconotide: neuronal calcium channel blocker for treating severe chronic pain","volume":"11","author":"Miljanich","year":"2004","journal-title":"Curr Med Chem"},{"issue":"6813","key":"10.1016\/j.jpainsymman.2008.02.016_bib16","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/35047086","article-title":"Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence","volume":"408","author":"Bohn","year":"2000","journal-title":"Nature"},{"issue":"2\u20133","key":"10.1016\/j.jpainsymman.2008.02.016_bib17","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0304-3959(99)00214-6","article-title":"Interactions of intrathecally administered ziconotide, a selective blocker of neuronal N-type voltage-sensitive calcium channels, with morphine on nociception in rats","volume":"84","author":"Wang","year":"2000","journal-title":"Pain"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088539240800376X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088539240800376X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:01:25Z","timestamp":1760130085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088539240800376X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S088539240800376X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2008.02.016","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Intrathecal Ziconotide for Chronic Pain: An Open-Label Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2008.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}